STEM CELL TECHNOLOGY: EPIGENETICS, GENOMICS, PROTEOMICS, AND
METABONOMICS

Nuclear Transfer-Derived Epiblast Stem Cells Are Transcriptionally
and Epigenetically Distinguishable from Their Fertilized-Derived
Counterparts

JULIEN MARUOTTI,a,b,c,d XIANG PENG DAI,e VINCENT BROCHARD,b,d LUC JOUNEAU,b,d JUN LIU,f
AME¬¥ LIE BONNET-GARNIER,b,d HE¬¥ LE` NE JAMMES,b,d LUDOVIC VALLIER,g I. GABRIELLE M. BRONS,g
ROGER PEDERSEN,g JEAN-PAUL RENARD,a,b,d QI ZHOU,a,e ALICE JOUNEAU

a,b,d

aSino-French Laboratory LABIOCEM, Institute of Zoology, Chinese Academy of Sciences, Beijing, China;
bINRA, UMR 1198 Biologie du De¬¥veloppement et Reproduction, Jouy en Josas, France; cGraduate School of
Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, China; dENVA, Maison-Alfort, France;
eState Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing,
China; fInstitute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China;
gLaboratory for Regenerative Medicine, Department of Surgery, University of Cambridge, Cambridge,
United Kingdom

Key Words. Reprogramming ‚Ä¢ Nuclear transfer ‚Ä¢ Cloning ‚Ä¢ Pluripotent stem cells

ABSTRACT
Mouse embryonic pluripotent stem cells can be obtained
from the inner cell mass at the blastocyst stage (embryonic
stem cells, ESCs) or from the late epiblast of postimplanta-
tion embryos (epiblast stem cells, EpiSCs). During normal
development, the transition between these two stages is
marked by major epigenetic and transcriptional changes
including DNA de novo methylation. These modiÔ¨Åcations
represent an epigenetic mark conserved in ESCs and
EpiSCs. Pluripotent ESCs derived from blastocysts gener-
ated by nuclear transfer (NT) have been shown to be cor-
rectly reprogrammed. However, NT embryos frequently
undergo abnormal development. In the present study, we
have examined whether pluripotent cells could be derived
from the epiblast of postimplantation NT embryos and
whether the reprogramming process would affect the epige-
netic changes occurring at this stage, which could explain

abnormal development of NT embryos. We showed that
EpiSCs could be derived with the same efÔ¨Åciency from NT
embryos and from their fertilized counterparts. However,
gene expression proÔ¨Åle analyses showed divergence between
fertilized- and nuclear transfer-EpiSCs with a surprising
bias in the distribution of the differentially expressed genes,
30% of them being localized on chromosome 11. A majority
of these genes were downregulated in NT-EpiSCs and
imprinted genes represented a signiÔ¨Åcant fraction of them.
Notably, analysis of the epigenetic status of a downregulated
imprinted gene in NT-EpiSCs revealed complete methyla-
tion of the two alleles. Therefore, EpiSCs derived from NT
embryos appear to be incorrectly reprogrammed, indicating
that abnormal epigenetic marks are imposed on cells in NT
embryos during the transition from early to late epiblast.
STEM CELLS 2010;28:743‚Äì752

Disclosure of potential conÔ¨Çicts of interest is found at the end of this article.

INTRODUCTION

Mouse embryonic pluripotent cells can be derived from the
early epiblast cells within the inner cell mass (ICM) at
the blastocyst stage (embryonic stem cells, ESCs) or from the

late epiblast of postimplantation embryo (epiblast stem cells
[1, 2], EpiSCs). Although these pluripotent stem cells share
the same core transcriptional network including the pluripo-
tency factors Oct3/4, Sox2, and Nanog, they differ not only
by their culture condition requirements but also by the extent
of their contribution to chimeras: only ESCs can integrate

J.M.: conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing; X.P.D. and V.B.:
provision of study material; J.M. and X.P.D.: contributed equally to this work; L.J. and J.L.: data analysis and interpretation; A.B.:
karyotype analysis; H.J.: bisulÔ¨Åte conversion and sequence analysis; L.V.: conception and design, text editing; I.G.M.B. and R.P.: help
with EpiSC derivation, scientiÔ¨Åc advice; Q.Z.: Ô¨Ånancial and administrative support, scientiÔ¨Åc advice; J.R.: Ô¨Ånancial and administrative
support, data analysis and interpretation, manuscript writing, Ô¨Ånal approval of manuscript; A.J.: conception and design, data analysis and
interpretation, manuscript writing, Ô¨Ånal approval of manuscript.

Correspondence: Alice Jouneau, UMR Biologie du Developpement et Reproduction, Bat 230, INRA domaine de Vilvert, 78352 Jouy-en-Josas
cedex, France. Telephone: 33 1 34 65 25 68; Fax: 33 1 34 65 23 64; e-mail: alice.jouneau@jouy.inra.fr; or Qi Zhou, Chinese Academy of
Sciences, Institute of Zoology, State-Key Laboratory of Reproductive Biology, 1 Beichen West Road, Chaoyang District, Beijing 100101, P.R.
China. Telephone: 86-10-64807050; Fax: 86-10-64807316; e-mail: qzhou@ioz.ac.cn Received December 15, 2009; accepted for publication
February 16, 2010; Ô¨Årst published online in STEM CELLS EXPRESS March 3, 2010. VC AlphaMed Press 1066-5099/2009/$30.00/0 doi: 10.
1002/stem.400

STEM CELLS 2010;28:743‚Äì752 www.StemCells.com

744

Derivation of EpiSCs from Nuclear-Transfer Embryos

properly within the host blastocyst and contribute to the germ-
line [1, 2]. Moreover, their epigenetic status differs, reÔ¨Çecting
the modiÔ¨Åcations accompanying the transition from naƒ±¬®ve epi-
blast to advanced, pregastrulating epiblast [3, 4]. These modi-
Ô¨Åcations include the de novo methylation of the genome and
the X-inactivation process [5‚Äì8].

several

Reprogramming somatic nuclear activity through nuclear
transfer (NT) has been shown to give rise to fertile adults. It
is commonly admitted that low efÔ¨Åciency of successful devel-
opment is correlated by incomplete or error-prone epigenetic
reprogramming. Indeed, chromatin modiÔ¨Åcations such as his-
tone marks and DNA methylation have been shown to be
affected after NT not only in early embryos but also in ani-
mals after birth [9‚Äì12]. However,
studies have
reported that ESCs derived from NT blastocysts (NT-ESCs)
are fully pluripotent and have a normal epigenetic status.
Moreover, they have been shown to be equivalent to their fer-
tilized (FT) counterparts for their transcriptome, proteome,
and miRNA proÔ¨Åles [13‚Äì15]. Strikingly, NT-ESCs are derived
from blastocysts which frequently exhibit abnormal features
in terms of both morphology [16] and transcriptional activities
[17]. Moreover, we have shown that defects present in the
ICM were mainly responsible for the loss of embryos at peri-
implantation stages [18]. In view of these results, the similar-
ity of NT-ESCs and FT-ESCs is intriguing and suggests either
that the defects in the NT-ICM do not affect derivation of ES
cells in vitro or that a normal pattern of gene expression is
acquired during the in vitro culture period required to estab-
lish ESC lines. Alternatively, but not exclusively, it can be
hypothesized that NT-ESCs might be derived from a subset
of correctly reprogrammed NT-ICM cells.

Furthermore, most of

the early postimplantation NT
embryos clearly exhibit abnormal developmental features, origi-
nating from defects in both the epiblast and the trophoblast [18,
19]. We therefore decided to derive and to study EpiSCs from
NT embryos to examine whether the reprogramming processes
affect the maintenance of pluripotency in the postimplantation
epiblast and the building of the epigenetic barrier separating
ESCs and EpiSCs. Our data show that NT-EpiSCs are transcrip-
tionally and epigenetically different from FT-EpiSCs. This is in
contrast to the results obtained with FT-ESCs versus NT-ESCs
and suggests that pluripotent cell
lines from NT embryos at
advanced developmental stages have kept the memory of epige-
netic alterations occurring during the in vivo establishment of the
epigenetic barrier in the epiblast around the implantation time.

MATERIALS AND METHODS

Animals
A transgenic mouse line (C57Bl6/J) carrying the gene for green
Ô¨Çuorescent protein (GFP) under the control of the GOF18 frag-
ment of the Oct4 promoter was used. The genetic construction
was described elsewhere [20] and mice were kindly provided by
Professor Zhangjian (Institute of Genetics and Developmental
Biology, Chinese Academy of Sciences).

For nuclear-transfer experiments, oocytes and cumulus donor
cells were retrieved from B6D2F1 or from Oct4-GFP B6D2F1 mice.
Controls were embryos that were fertilized in vivo (B6D2F1).

All animals were maintained in accordance with the guide-
lines for the care and use of laboratory animals established by the
Beijing Association for Laboratory Animal Science.

Somatic Cell Nuclear Transfer
Nuclear transfer of cumulus nuclei into enucleated oocytes was
performed as previously described [21]. BrieÔ¨Çy, embryos were

reconstructed by injection of cumulus nuclei
into enucleated
oocytes from superovulated females and then activated with
strontium in CZB medium. Embryos were transferred at the two-
cell stage into pseudo-pregnant ICR females.

Derivation and Culture of EpiSC Lines
EpiSC lines were derived as previously described [1]: epiblasts
from pre-streak/early-streak E7 NT or E6.5 control embryos were
cultured in completely deÔ¨Åned medium complemented with 20
ng/ml Activin A (R&D Systems Inc., Minneapolis, http://www.
rndsystems.com; catalog no. 338-AC) and 12 ng/ml Ô¨Åbroblast
growth factor 2 (FGF2; R&D Systems; catalog no. 223-FB). Plu-
ripotent-looking colonies were mechanically picked and expanded
before routine passage with collagenase II
(Sigma-Aldrich,
St. Louis, http://www.sigmaaldrich.com; catalog no. C6885). Dur-
ing picking and the Ô¨Årst rounds of passages, culture dishes were
coated with 10 ll/ml Ô¨Åbronectin (Chemicon International, Teme-
cula, CA, http://www.chemicon.com; catalog no. FC-010) before
switching to fetal calf serum coating. All cell lines were used
between passages 10 and 20.

catalog

instructions

http://www.roche-applied-science.com;

Immunohistochemistry
staining was performed according to
Alkaline phosphatase
(Roche Diagnostics, Basel,
the manufacturer‚Äôs
Switzerland,
no.
11681451001). For immunoÔ¨Çuorescence, outgrowths, and EpiSCs
were Ô¨Åxed in 4% paraformaldehyde at 4C overnight. They were
then permeabilized with 0.5% Triton X-100 for 1 hour at room tem-
perature, before blocking with 2% bovine serum albumin in phos-
phate buffered saline. Incubation was carried out overnight at 4C
with the following antibodies: goat a-Oct4 (monoclonal 1:100), rab-
bit a-Sox2 (monoclonal 1:500), and mouse a-SSEA-I (monoclonal
1:75) were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA,
http://www.scbt.com); rabbit a-Nanog (monoclonal 1:100) was from
Chemicon International. Secondary antibodies (FITC or Cy5-conju-
gate from ZhongShan Biotechnology Co., Ltd, Beijing, PRC) were
used for detection as appropriate. Nuclei were counterstained with
propidium iodide (Sigma-Aldrich). Observations were made with an
epiÔ¨Çuorescence microscope (Leica, Heerbrugg, Switzerland, http://
www.leica.com) or a LSM 510 META confocal microscope (Carl
Zeiss, Jena, Germany, http://www.zeiss.com).

BisulÔ¨Åte Genomic Sequencing
DNA was extracted from cumulus cells, E13.5 fetuses, and EpiSC
lines. BisulÔ¨Åte treatment was performed as previously described
[22]. Primers for Snrpn/Snurf and polymerase chain reaction
(PCR) conditions used to amplify products from bisulÔ¨Åte-treated
DNA were described elsewhere [23]. The ampliÔ¨Åed region corre-
sponds to the DMR1 encompassing the transcription start site and
containing 16 CpG residues. AmpliÔ¨Åed products were sequenced
by Cogenics (Beckman Coulter Genomics, Takeley, United King-
dom, https://www.cogenicsonline.com)

Reverse Transcription-Polymerase Chain Reaction
(RT-PCR) and Quantitative RT-PCR Analysis
Total RNAs were extracted using the RNeasy minikit (Qiagen,
Hilden, Germany,
http://www1.qiagen.com) with DNaseI
treatment and reverse-transcribed with superscript II reverse tran-
scriptase (Invitrogen, Carlsbad, CA, http://www.invitrogen.com).
FT- and NT-ESC samples were obtained from a previous study
[24]. PCR was done as previously described [1]. Real-time PCR
was run in triplicate on a Step One plus (Applied BioSystems,
Foster City, CA, http://www.appliedbiosystems.com) and expres-
sion data normalized by the expression level of b-Actin (Actb).
Primer pairs for quantitative RT-PCR were all from Primer Bank
(http://pga.mgh.harvard.edu/primerbank):
(ID
15029532a1), Ndn (ID 31981598a1), Peg3 (ID 6561146a1), Krt19
(ID 6680606a1), and Gusb (ID 6754098a1) except for Actb (for-
ward: 50-GCTCTGGCTCCTAGCACCAT-30; reverse: 50-GCCAC
CGATCCACACCGCGT-30).

Snrpn/Snurf

Maruotti, Dai, Brochard et al.

745

Figure 1. Morphology of fertilized (FT) and nuclear transfer (NT) embryos. Bright-Ô¨Åeld image of FT and NT-derived embryos at prestreak
stage (scale bar: 100 lm) and distribution of the different morphologies among NT embryos. FT embryos were dissected at E6.5 and NT
embryos were dissected at E7. Abbreviation: large ExE, large extraembryonic ectoderm.

Mitotic Index Determination
FT and NT outgrowths were stained for Oct4 and counterstained
with propidium iodide. Optical sectioning was carried out using a
confocal microscope (LSM 510 META; Carl Zeiss) and the num-
ber of mitotic Ô¨Ågures was counted on each slice using ImageJ
software (http://rsb.info.nih.gov/ij/Java1.3.1_13). A total of 750-
1,000 cells across different optical sections were counted in each
sample.

5-Bromo-20-deoxy-uridine Incorporation Assay
Cell proliferation assays were carried out according to the manu-
facturer‚Äôs instruction (Roche Diagnostics; 5-Bromo-20-deoxyuri-
dine [BrdU] labeling kit, catalog no. 11 296 736 001). For each
cell line (passages 10-15), cells from three independent biological
repeats were labeled and about 250 cells counted in each.

Gene Expression Analysis Using Microarray
For each EpiSC line, total RNAs were extracted from two to
three independent biological repeats. For male and female pre-
streak embryos, total RNAs were extracted from 3 pools of 10
embryos, each of the same sex. Hybridizations were performed
using the Illumina array Mouse WG-6 V2.0 expression BeadChip.
Raw data were analyzed using BeadStudio v3 software (Illumina
Inc., San Diego, CA, http://www.illumina.com). Values were nor-
malized and log2 transformed under R software. To obtain the
list of differentially expressed probes, we used a Student‚Äôs t test
(limma R package, 2004) and p values were adjusted using the
Benjamini-Hochberg method for false discovery rate control [25].
Transcriptomic data are accessible in the Gene Expression Omni-
bus with the accession number GSE17402.

Embryoid Body Formation
Embryoid bodies (EBs) were produced as described previously
[1]. BrieÔ¨Çy, Ô¨Çoating EpiSC clumps were cultured for 6 days in
Dulbecco‚Äôs modiÔ¨Åed Eagle‚Äôs medium with 10% fetal calf serum.
Resulting EBs were plated on 0.1% gelatin-coated dishes and cul-
tured for 10 days.

Statistical Analysis
Statistical analyses were carried out using SPSS 13.0. v2,
Kruskal-Wallis, and ANOVA tests were used when appropriate,
with a signiÔ¨Åcant value of p < .05.

www.StemCells.com

RESULTS

transfer

FT- and NT-EpiSC Are Similar in Terms of Marker
Expression and In Vitro Differentiation
Pre-streak/early-streak NT embryos obtained from somatic
cell nuclear
(SCNT) were dissected at E7 and
grouped according to their morphological aspect (Fig. 1). The
different classes of morphology were previously deÔ¨Åned using
ESCs as donor nuclei [18]. With use of the same criteria, 16
SCNT embryos out of 38 (44%) exhibited morphology similar
to that of controls and belonged to the ‚Äò‚Äònormal‚Äô‚Äô class. Nine-
teen percent of NT embryo epiblasts had a size inferior to
their extraembryonic ectoderm (ExE) and this group was
deÔ¨Åned as ‚Äò‚Äòlarge extraembryonic ectoderm‚Äô‚Äô
(large ExE)
embryos. 19% of the epiblasts were more spherical than elon-
gated and wider than the ExE and were classed in the ‚Äò‚Äòround
shape‚Äô‚Äô category. Finally, 17% of the NT embryos displayed a
very perturbed morphology with no clear distinction between
the embryonic and extraembryonic compartment and were
consequently considered as belonging to the ‚Äò‚Äòvesicular shape‚Äô‚Äô
category.

Epiblasts could be successfully isolated from all the dif-
ferent NT-embryo categories except for the vesicular shape
category. The resulting clump of cells was grown in a deÔ¨Åned
medium supplemented with Activin and FGF2 [1] until
it
formed an outgrowth from which pluripotent colonies were
identiÔ¨Åed using morphological criteria (tightly packed colo-
nies of smooth appearance, with large nuclei). These colonies
were picked and expanded in the same culture conditions.
After several rounds of mechanical passage, stable and pluri-
potent-looking cell lines were obtained with a similar efÔ¨Å-
ciency from FT and NT embryos (Table 1). Both kinds of
cell lines were passaged every 2 or 3 days and were morpho-
logically similar (Fig. 2A).

When the last type of embryos (vesicular shape) was cul-
tured, they rarely formed an outgrowth and did not give rise
to any EpiSC line. ImmunoÔ¨Çuorescence analysis indicated
that no cell of outgrowth from vesicular shape embryos
expressed Oct4, a key marker of pluripotency [26] (data not
shown).

Three FT-EpiSC lines (FT.1, FT.2, and FT.3) and three
NT-EpiSC lines
(NT.1 and NT.2 derived from normal
embryo, NT-LE derived from large ExE embryo) were
selected for further analyses. FT and NT lines expressed
markers of pluripotency including Oct4, Nanog, Sox2, and

746

Derivation of EpiSCs from Nuclear-Transfer Embryos

Table 1. EfÔ¨Åciency of derivation of EpiSC lines from FT and NT embryos

Type of embryo

No. of epiblasts

No. of outgrowths

No. of lines derived

Embryo morphology

FT
NT

18
17

18
15a

5
5

normal

2 Normal, 2 large ExE, 1 round shape

Rateb (%)

27.8
33.3

No statistical difference was found in the derivation efÔ¨Åciency between fertilized and NT EpiSC.
aTwo epiblasts belonged to the vesicular shape class and did not develop into an outgrowth.
bThe rate is calculated from the ratio between the number of derived lines and the number of outgrowths.Abbreviations: EpiSC, epiblast
stem cell; ExE, extraembryonic ectoderm; FT, fertilized; NT, nuclear transfer.

Figure 2. Characterization of derived EpiSC lines. (A): Phase contrast images of FT- and NT-EpiSCs (scale bar: 50 lm). (B): ImmunoÔ¨Çuores-
cence staining of FT- and NT-EpiSC for Oct4, Nanog, and Sox2 as indicated (scale bar: 10 lm). (C): Alkaline phosphatase staining of FT- and
NT-EpiSCs and mouse ESCs (scale bar: 10 lm). EpiSCs are alkaline phosphatase negative, as expected. (D): Reverse-transcription-polymerase
chain reaction (RT-PCR) analysis of pluripotency and speciÔ¨Åc markers in FT- and NT-EpiSCs. Mouse ES cells were used as positive control for
Stella expression. (E): RT-PCR analysis of markers of differentiation in embryoid bodies derived from FT- and NT-EpiSCs and plated for 10
days. Abbreviations: EpiSCs, epiblast stem cell; ESCs, embryonic stem cell; FT, fertilized; NT, nuclear transfer.

stained negatively for alkaline phosphatase
SSEA-1 but
(Fig. 2B, 2C and data not shown). RT-PCR analyses con-
Ô¨Årmed the expression of pluripotency markers and epiblast
markers such as FgF5 and Nodal in both FT- and NT-EpiSCs
(Fig. 2D). As expected, FT- and NT-EpiSCs did not express
the germ cell-speciÔ¨Åc marker Stella (Fig. 2D). Taken together,
these data indicate that FT- and NT-EpiSCs express markers
characterizing EpiSCs [1, 2] and thus validate their embryonic
identity.

Importantly, FT- and NT-EpiSCs were able to form EBs
that gave rise to various tissues, including Ô¨Åbroblast-like cells,
liver-like cells, and beating cells once grown in adherent cul-
ture conditions (data not shown). Presence of derivatives of
the three primary germ layers was conÔ¨Årmed by RT-PCR
analyses, showing that plated EBs from FT- and NT-EpiSCs
expressed markers
differentiation

neuronal

speciÔ¨Åc

for

(Tubb3, Six3, and Neurod1; Fig. 2E), mesoderm differentia-
tion (Brachyury [early mesoderm], Vimentin and Myod1
[myogenic tissues], and Pecam1 [vascular tissues]; Fig. 2E),
and endoderm differentiation (Gata6, Pdx1, and Foxa2; Fig.
2E). Together,
these results show that FT- and NT-EpiSC
lines are able to differentiate into derivatives of the three pri-
mary germ layers in vitro.

FT- and NT-EpiSC Lines Proliferate at the
Same Rate
Interestingly, we observed that the mitotic index of a large
proportion (41%) of epiblasts from postimplantation cloned
embryos signiÔ¨Åcantly differs from controls [18], suggesting
that NT- and FT-EpiSCs could have different rates of prolifer-
ation. To conÔ¨Årm this hypothesis, we used BrdU incorporation

Maruotti, Dai, Brochard et al.

747

assays to determine the cell proliferation in the different
EpiSC lines. After only 5 minutes of BrdU pulse, 70% of
cells were stained in FT and NT lines (supporting information
Fig. 1A, 1B), and after 1 hour of BrdU incubation, this per-
centage rose to 78%. Statistical comparison indicated no sig-
niÔ¨Åcant difference between rates of BrdU incorporation in
FT- and NT-EpiSC lines. Therefore, cell proliferation rates
are similar between FT- and NT-EpiSCs.

FT and NT Outgrowths Display a Similar Dynamic
Pattern of Oct4 Expression
The results described above suggested that the differences in
cell proliferation observed between FT and NT epiblasts in
vivo were lost in vitro. Therefore, we decided to examine
whether these difference were still present when pluripotent
primary colonies of EpiSCs were formed at the outgrowth
stage. Once plated on Ô¨Åbronectin,
isolated epiblasts grew
actively and formed an outgrowth in which EpiSC pluripotent
primary colonies were easily recognized by their morphology.
Oct4 is a key marker of pluripotency [26] expressed in EpiSC
lines and lost upon their differentiation [1]. To follow the
dynamics of Oct4 expression pattern during the outgrowth
phase in FT- and NT-EpiSC line derivation, we used embryos
expressing the GFP under the control of the Oct4 promoter
[20]. During our observations, we noticed that Oct4-express-
ing cells always had pluripotent morphology, although the
contrary was not always true. Moreover, EpiSC lines were
derived only from GFP-positive colonies and never arose
from cells negative for Oct4 expression (data not shown).

Two patterns of Oct4 expression were observed (Fig. 3A,
3B) in FT and NT outgrowths: (i) From day 1 to days 3-4 of
in vitro culture, there was a progressive decrease of the Oct4-
expressing cell population, before its rise during the next 4-8
days, until Oct4-expressing colonies were large enough for
picking and subsequent EpiSC derivation. This pattern was
followed by 36% (4/11) and 44% (4/9) of FT and NT out-
growths, respectively. (ii) From day 1 to days 3-5 of in vitro
culture, the Oct4-expressing cell population progressively dis-
appeared and did not reappear. This happened in 64% (7/11)
of the FT outgrowths, versus 56% (5/9) for their NT counter-
parts. The same distribution within the two patterns was found
for the two types of outgrowths. Therefore, the derivation pro-
cess appears very similar for NT and FT epiblasts.

In Oct4-Expressing Areas, Cell Proliferation
Differences Between FT and NT Outgrowths
Fade Away During In Vitro Culture
To conÔ¨Årm these observations, we performed immunostaining
analyses for the expression of Oct4 and compared the cell
proliferation in FT versus NT outgrowths. Since EpiSC lines
were derived from Oct4-positive primary colonies within the
outgrowths, we decided to deÔ¨Åne the proliferation rate of this
particular cell population. First, the Oct4 expression pattern
previously observed in FT and NT outgrowths with the Oct4-
GFP construct was conÔ¨Årmed by immunoÔ¨Çuorescence after 24
hours, 4 days, and 10 days of in vitro culture (supporting in-
formation Fig. 2). Then we used mitotic index to assess cell
proliferation. Importantly, preliminary experiments with BrdU
were unsuccessful because of the limited penetration of BrdU
into the outgrowth inner cells. Two time points were chosen:
after 24 hours of in vitro culture, when the outgrowth was
mainly composed of Oct4-positive cells and has just started to
spread, and after 10 days, when Oct4-positive EpiSC primary
colonies were usually picked (supporting information Fig. 2).
For each time point, mitotic indexes were determined for
5-10 outgrowths of each type (FT and NT).

www.StemCells.com

Interestingly, when we compared the mitotic index of Oct4-
positive and -negative cell colonies within FT and NT out-
growths kept 10 days in culture, we found that in FT and NT
outgrowths, Oct4-positive cell colonies had a signiÔ¨Åcantly
higher proliferation rate than the Oct4-negative‚Äîdifferenti-
ated‚Äîcolonies (data not shown). Then we looked at Oct4-
expressing areas only and we found that most of the mitotic
indexes were comprised between 4% and 12% after 24 hours
(Fig. 3C) and between 3% and 8% at 10 days of in vitro culture.
The cell proliferation was signiÔ¨Åcantly lower in NT outgrowths
(Fig. 4C) after 24 hours of in vitro culture whereas no differ-
ence could be detected after 10 days. Consequently, growth
deregulations observed in NT epiblasts in vivo [18] could still
be detected in vitro after 24 hours of culture, but disappeared
after a prolonged period of culture. Since EpiSC derivation efÔ¨Å-
ciency from FT and NT outgrowths was comparable (Table 1),
these results reveal the existence of mechanisms by which cell
proliferation defects in the Oct4-expressing cells of the NT out-
growths are corrected by in vitro culture.

FT and NT-EpiSCs Are Distinguishable on the
Transcriptomic Level
FT- and NT-EpiSC lines could not be distinguished by their
self-renewal property or their capacity of differentiation. There-
fore, we decided to further characterize NT- and FT-EpiSCs by
performing gene expression proÔ¨Åling. However, some of our
FT-EpiSC lines were male (namely, FT.1 and FT.2), whereas
all the NT lines were female. To exclude sex-related differences
from our subsequent analyses, we compared the transcriptomic
proÔ¨Åle of pre-streak male and female whole embryos: with an
adjusted p value <.05 for the Student‚Äôs t test we could not
detect differential gene expression between male and female
(data not shown). These results reinforced previous studies
showing the limited inÔ¨Çuence of sex on gene expression in
ESCs [27]. Then we performed a hierarchical clustering for all
six EpiSC lines (Fig. 5A), and surprisingly, individual EpiSC
line expression proÔ¨Åles grouped into two main clusters (Fig.
5B). One that included three FT lines plus NT.1 and thus was
named ‚Äò‚ÄòFT-like‚Äô‚Äô and one that comprised NT-LE and NT.2
lines and was named ‚Äò‚Äòabnormal‚Äô‚Äô. Hence, nuclear transfer-
derived embryos seem able to give rise to NT-EpiSC lines that
have expression proÔ¨Åles similar to their control counterparts,
and also to NT-EpiSC lines that behave differently on the tran-
scriptional level.
Further analyses revealed that 111 (out of 16061) tran-
scripts were signiÔ¨Åcantly (Student t test with p  .05) up- or
downregulated between the two groups. Among them, 80%
are downregulated in abnormal NT-EPiSCs. Twenty-Ô¨Åve were
differentially expressed with a twofold change or more (Table
2). Noteworthy, the most affected transcripts (dysregulations
with folds superior to 10) were all downregulated and they all
correspond to imprinted genes such as Snrpn/Snrpn upstream
reading frame (Snrpn/Snurf), necdin (Ndn), mesoderm-speciÔ¨Åc
transcripts (Mest), imprinted and ancient (Impact), and pater-
nally expressed 3 (Peg3) [28].

In the course of our microarray data analysis, we also
found that an unusually high proportion (30%, 32/111) of dif-
ferentially expressed transcripts originated from genes present
on chromosome 11. To conÔ¨Årm this observation, we com-
pared the distribution of the transcripts expressed in EpiSCs
(FT or NT) on the 20 pairs of chromosomes to that of the dif-
ferentially expressed transcripts (Fig. 5D). Statistical analysis
 13) conÔ¨Årmed that there was a clear bias in the
(v2, p < 10
location of the genes that have a perturbed expression in
abnormal NT-EpiSC lines. To test
the
bias was due to a structural defect affecting chromosome

the possibility that

748

Derivation of EpiSCs from Nuclear-Transfer Embryos

Figure 3. Oct4 expression pattern in FT
and NT outgrowths at different time points
and Mitotic Index of the Oct4-expressing
cell population. (A): Diagram depicting the
evolution of Oct4-expressing cell popula-
tion in FT and NT outgrowths. (B): Expres-
sion of the green Ô¨Çuorescent protein under
the control of the Oct4 promoter in FT and
NT outgrowths at different time points as
indicated (scale bar: 100 lm). Only out-
growths that could be successfully picked
for epiblast stem cell derivation are shown.
(C): The mitotic indexes were calculated in
the outgrowths derived from fertilized or
NT embryos and represented individually as
dot-plots. Bars indicate the mean. *, p <
.05. Abbreviations: FT,
fertilized; GFP,
green Ô¨Çuorescent protein; LE, Large ExE
embryo; Nor., normal embryo; NT, nuclear
transfer; RS, round shape embryo; SCNT,
somatic cell nuclear transfer.

excluding that one particular genomic region could have
been affected by some subtle structural abnormalities (sup-
porting information Fig. 4).

Finally, these results were conÔ¨Årmed by performing quan-
three

showing (Fig. 5E)

titative RT-PCR analyses

that

11, we analyzed the karyotype of our EpiSC lines after
G-banding staining. No obvious anomaly affecting NT-
EpiSCs could be detected (supporting information Fig. 2). In
addition, genes downregulated in NT-EpiSCs and located on
chromosome 11 were mapped along this
chromosome

Maruotti, Dai, Brochard et al.

749

Figure 4. Transcriptomic analysis of FT- and NT-EpiSC lines. (A):
Hierarchical clustering of EpiSC line expression proÔ¨Åles: sample tree
for each biological repeat, named (a), (b), and (c). (B): Hierarchical
clustering of EpiSC lines expression proÔ¨Åles: sample tree for each line.
(C): Analysis of expression proÔ¨Åles. MSI of NT-LE and NT.2 lines
were plotted against the corresponding MSI of the three FT lines and
NT.1. Dotted lines indicate 1.5-fold regulation. Stars indicate transcripts
differentially expressed with a 1.5-fold or more change. (D): Chromo-
somal distribution of the transcripts present on the array (gray line) and
of the differentially expressed transcripts (gray bars). Abbreviations:
EpiSC, epiblast stem cell; FT, fertilized; GFP, green Ô¨Çuorescent protein;
LE, Large ExE embryo; MSI, mean signal intensities; NT, nuclear
transfer.

imprinted genes, Snrpn/Snurf, Ndn, and Peg, were drastically
downregulated in NT-LE and NT.2 compared to the FT-like
EpiSCs. To further demonstrate that downregulated expression
of these imprinted genes was a feature speciÔ¨Åc to NT-EpiSCs,
similar analyses were performed in FT- and NT-ESC lines,
showing that the expression of Peg3 and Ndn was normal in
these pluripotent cells (supporting information Fig. 5).

We also compared the level of expression of two other
dysregylated genes, keratin 19 (Krt19) and glucoronidase beta
(Gusb), by quantitative PCR (Fig. 5A). The results were in
accordance with the transcriptomic data, except
that NT.1
expression levels were in these cases closer to those of NT.2
and NT-LE than to the FT lines. This result shows that, for at
least some genes, NT.1 tends to behave like the other NT-
EpiSC lines. It is in accordance with the data from the hier-
archical clustering (Fig. 4A), where the cluster comprising the
NT.1 biological repeats was branched between the FT lines
cluster, and the NT-LE and NT.2 cluster.

Taken together, these results demonstrate that derivation
of EpiSCs from NT-embryo transfer can generate pluripotent
lines incorrectly reprogrammed and genes located on chromo-
some 11 appear to be speciÔ¨Åcally targeted by these reprog-
ramming errors.

FT- and NT-EpiSCs Are Distinguishable on the
Epigenetic Level
Imprinted gene expression can be controlled by differentially
methylated regions (DMRs) with methylation patterns speciÔ¨Åc
to the maternal or paternal allele [22]. Therefore, we won-

www.StemCells.com

Figure 5. ConÔ¨Årmation of the transcriptomic data by quantitative
reverse transcription-polymerase chain reaction (RT-PCR) and DNA
methylation analysis of Snrpn and Peg3. (A): Expression levels of
selected genes measured by quantitative RT-PCR in the FT- and NT-
EpiSC lines. Expression levels with different letters were signiÔ¨Åcantly
different (p < .05). Bars show the standard deviation. (B): DNA
methylation analysis of FT- and NT-EpiSC, foetus lines and cumulus
cells by bisulÔ¨Åte conversion followed by direct sequencing for Snrpn/
Snurf differentially methylated region 1. Sixteen CpG residues were
analyzed: presence of C or T indicates a methylated or unmethylated
residue, respectively. Abbreviations: EpiSC, epiblast stem cell; FT,
fertilized; NT, nuclear transfer.

dered if the perturbation of this methylation pattern could
be responsible for the decrease in expression observed in
NT-EpiSCs. To validate this hypothesis, we checked the DNA
methylation status of one of the most dramatically downregu-
lated imprinted genes, Snrpn/Snurf. Importantly, this gene is
known to have stable and robust imprint that is not affected
by environmental parameters such as long-term passages of
cells and embryo culture [29]. In sum, the methylation status
of the DMR was determined using bisulÔ¨Åte genomic sequenc-
ing (Fig. 5B and supporting information Fig. 6) and the pres-
ence of polymorphism at all CpG sites was evidenced in the
FT-EpiSCs and somatic tissues, in accordance with a methyla-
tion of maternal alleles and a demethylation of paternal alleles
[30]. However, a loss of polymorphism was found at all CpG
positions in NT-EpiSCs. The two abnormal NT-EpiSCs (NT.2
and NT-LE) displayed a full methylation, suggesting a meth-
ylation of both parental alleles. By contrast, we observed a
nearly complete demethylation of the Snrpn/Snurf DMR for

750

Derivation of EpiSCs from Nuclear-Transfer Embryos

Table 2. List of transcripts differentially expressed between
EpiSC lines belonging to the abnormal and the FT-like cluster
(adjusted p value <.05; fold change 2)
Symbol

Fold change

Student‚Äôs t test adjusted p value

47.9
16
12.4
11.7
10.5
6.6
4.3
3.1
2.9
2.9
2.8
2.7
2.7
2.7
2.6
2.6
2.5
2.3
2.1
2.0

Downregulated transcripts in NT.2 and NT-LE
Snrpn/Snurf
Ndn
Mest
Impact
Peg3
LOC666403
Pcsk9
Stl4
Supt16h
Tomm22
1700123O20Rik
Adamts9
C920004C08Rik
LOC100044289
Mkrn3
Krt19
Rpol-2
Zfp365
Krt18
Rpo1-4
Upregulated transcripts in NT.2 and NT-LE
GusB
Cdknlc
Prickle4
Chacl
Cyba

2.1
2.3
2.6
2.6
2.8

2.52  10
7.25  10
2.52  10
2.14  10
2.73  10
.039
.010
7.24  10
1.09  10
.028
4.94  10
.032
5.71  10
1.54  10
1.09  10
.016
.018
2.12  10
.030
6.76  10

 5
 5
 5
 3
 4

 4
 4

 5

 4
 3
 4

 3

 3

.041
4.13  10
.027
5.90  10
.033

 3

 3

Abbreviation: EpiSC, epiblast stem cell.

the NT.1 EpiSC line. Therefore, repression of Snurf/Snrpn
expression in the abnormal NT-EpiSCs could be explained by
allelic silencing through methylation. Taken together, these
results conÔ¨Årm that that there are clear-cut epigenetic differ-
ences between FT- and NT-EpiSCs at the single-gene level.

DISCUSSION

Divergences Between EpiSC Derived from NT
Embryos or Fertilized Counterparts
In this study, we showed that EpiSCs can be derived with the
same efÔ¨Åciency from NT embryos and from fertilized
embryos. NT-EpiSCs appear to behave similarly to their FT
counterpart as they show the same capacity to proliferate, to
express markers of pluripotency such as Oct4, Nanog, and
Sox2 and to form embryoid bodies capable of differentiating
into derivatives of the three germ layers. However, our study
also revealed that NT and FT cell lines can also display diver-
gent gene expression proÔ¨Åles. The expression of imprinted
genes appears to be particularly variable because of an abnor-
mal methylation pattern of these genomic regions in NT-
EpiSCs. This is in striking contrast to the data obtained with
ESC lines isolated from NT or FT blastocysts [13, 14]. ESCs
and EpiSCs are both obtained from the epiblast, but at differ-
ent developmental periods, respectively the blastocyst and the
pregastrula stages. This suggests that
the epigenetic errors
imposed on embryonic cells during the process of reprogram-
ming become apparent during the transition from early to late
epiblast stages.

Nevertheless, the observation that the mean mitotic index
of Oct4-expressing cells in NT-epiblast-derived outgrowths is

initially low, but becomes similar to FT epiblast-derived ones
after 10 days of culture indicates that an in vitro culture pe-
riod may be able to correct some of the pre-existing cellular
defects induced by the NT procedure. Alternatively, the more
correctly reprogrammed pluripotent cells within an outgrowth
could gain a selective advantage, and further partial reprog-
ramming could also take place during the in vitro culture.
Interestingly, this hypothesis is reinforced by a recent report
demonstrating that human-induced pluripotent
stem cells
(hiPSC) at late passage are closer to hESCs than hiPSCs at
early passage [31].

Impact, Peg3) were all

Difference in Imprinted Gene Expression Between
‚Äò‚ÄòAbnormal‚Äô‚Äô NT-EpiSCs and ‚Äò‚ÄòFT-like‚Äô‚Äô EpiSCs
Among the transcripts found differentially expressed between
‚Äò‚Äòabnormal‚Äô‚Äô and ‚Äò‚ÄòFT-like‚Äô‚Äô EpiSC, the most dysregulated ones
(Snrpn/Snurf, Ndn, Mest,
from
imprinted genes. Such genes can have a perturbed expression
in embryos because of incorrect epigenetic reprogramming af-
ter NT [32, 33] or in ESCs as a result of accumulated epi-
mutations occurring during in vitro culture [34, 35]. Several
reports have shown the epigenetic stability of Snrpn/Snurf,
Ndn, and Peg3 in mESCs [29, 36] and hESCs [37‚Äì39] during
long-term in vitro culture. After nuclear transfer, disruption of
methylation for Snrpn/Snurf and Peg3 has been evidenced in
NT blastocysts and one NT-ESC line, respectively [32, 36].
Noteworthy, all the reported cases of perturbations affecting
imprinted genes show a loss of imprint and biallelic expres-
sion, whereas in the present study we report repression of
expression in some NT-EpiSCs lines. Moreover, we have
been able to correlate the repression of expression of Snrpn/
Snurf with hypermethylation of the DMR region, supporting
the view that
the paternal allele has been silenced. Data
regarding expression of imprinted genes just after implanta-
tion in mouse NT embryos are limited and only Snrpn/Snurf,
Ndn, and Peg have been found to be faithfully expressed in
livers of NT pups [40] and also Mest at 9.5 dpc [41]. Down-
regulation of Snrpn/Snurf and Ndn (together with Mkrn3)
induces postnatal lethality [42], whereas downregulation of
Mest results in embryonic growth retardation between E15
and E18 [43]. Therefore, concomitant downregulation of these
genes by abnormal methylation at the epiblast stage could
explain the wave of mortality observed just after implantation
and before E7 in NT embryos [18]. Noteworthy, another
imprinted gene Cdkn1c (p57) found upregulated in our abnor-
mal NT-EpiSC has been implicated in embryonic growth
retardation and lethality upon a twofold upregulation [44].

In addition, most of the imprinted genes strongly downre-
gulated in abnormal NT-EpiSCs are expressed in the brain
[43, 45‚Äì48] where some of them are known to play a crucial
role in neuronal differentiation [49‚Äì55]. Therefore, NT-EpiSC
lines could have limited capacity to generate functional neuro-
nal cells and further studies will focus on comparing neuronal
differentiation of FT and NT-EpiSCs.

Can Chromosome 11 Be Considered As a SpeciÔ¨Åc
Target for Dysregulated Gene Expression in
Abnormal NT-EpiSCs?
A puzzling result of our work is the bias that we have evi-
denced in the genomic localization of the genes found to be
downregulated in NT EpiSCs. A signiÔ¨Åcant fraction of these
genes are located on chromosome 11, suggesting a speciÔ¨Åc
involvement of this chromosome in abnormal development of
early postimplantation NT mouse embryos. Interestingly, pre-
dictive analyses have suggested that chromosome 11 is partic-
ularly enriched in genes essential for full-term development

Maruotti, Dai, Brochard et al.

751

[56]. In addition, this chromosome has also been shown in the
mouse to be particularly enriched in CpG islands at gene pro-
moters [57]. Together, these data suggest that chromosome 11
could require speciÔ¨Åc mechanisms to be reprogrammed. At
last, our observations provide an additional support
to the
view that epigenetic more than genetic defects account for the
high rate of compromised development observed after nuclear
transfer in the mouse once NT blastocysts have formed. We
cannot exclude that subtle chromosomic abnormalities affect-
ing chromosome 11, below the level of detection of the G-
banding analysis, could have occurred earlier during the pro-
cess of nuclear transfer itself or in vitro culture [58, 59].
However, the odds of chromosomal rearrangement occurring
on the same chromosome in two different NT-EpiSC lines but
not in FT-EPiSC lines is rather small. Extension of this result
to different genetic backgrounds
is underway in our
laboratory.

CONCLUSION

Taken together, our results demonstrate that the reprogram-
ming errors following nuclear transfer perturb the normal pro-
cess of epigenetic modiÔ¨Åcations occurring in the developing
epiblast. Inappropriate methylation can result
in abnormal
expression of a large set of genes, one-third of them being
located on chromosome 11. Recently, Bao and colleagues
have shown that EpiSCs can be reprogrammed into ES-like
cells, so called rESCs, showing that some epigenetic barriers
could be overcome in vitro [3]. In this regard, our model of
EpiSCs derived from NT embryos constitutes an original

REFERENCES

1 Brons IGM, Smithers LE, Trotter MWB et al. Derivation of pluripo-
tent epiblast stem cells from mammalian embryos. Nature 2007;448:
191‚Äì195.

2 Tesar PJ, Chenoweth JG, Brook FA et al. New cell lines from mouse
epiblast share deÔ¨Åning features with human embryonic stem cells.
Nature 2007;448:196‚Äì199.

3 Bao S, Tang F, Li X et al. Epigenetic reversion of post-implantation
epiblast to pluripotent embryonic stem cells. Nature 2009; 461(7268):
1292‚Äì1295.

4 Hayashi K, Lopes SMCdS, Tang F et al. Dynamic equilibrium and
heterogeneity of mouse pluripotent stem cells with distinct functional
and epigenetic states. Cell Stem Cell 2008;3:391‚Äì401.

5 Monk M, Boubelik M, Lehnert S. Temporal and regional changes in
DNA methylation in the embryonic, extraembryonic and germ cell
lineages during mouse embryo development. Development 1987;99:
371‚Äì382.

6 Rossant J, Sanford JP, Chapman VM et al. Undermethylation of struc-
tural gene sequences in extraembryonic lineages of the mouse. Dev
Biol 1986;117:567‚Äì573.

7 Kafri T, Ariel M, Brandeis M et al. Developmental pattern of gene-
speciÔ¨Åc DNA methylation in the mouse embryo and germ line. Genes
Dev 1992;6:705‚Äì714.
Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators
of pluripotency. Cell 2007;128:747‚Äì762.

8

9 Wang F, Kou Z, Zhang Y et al. Dynamic reprogramming of histone
acetylation and methylation in the Ô¨Årst cell cycle of cloned mouse
embryos. Biol Reprod 2007;77:1007‚Äì1016.

10 Shao GB, Ding HM, Gong AH et al. Inheritance of histone H3 meth-
ylation in reprogramming of somatic nuclei following nuclear transfer.
J Reprod Dev 2008;54:233‚Äì238.

11 Suzuki T, Kondo S, Wakayama T et al. Genome-wide analysis of

abnormal H3K9 acetylation in cloned mice. PLoS One 2008;3:e1905.

12 Ohgane J, Wakayama T, Kogo Y et al. DNA methylation variation in

cloned mice. Genesis 2001;30:45‚Äì50.

13 Brambrink T, Hochedlinger K, Bell G et al. ES cells derived from
cloned and fertilized blastocysts are transcriptionally and functionally
indistinguishable. Proc Natl Acad Sci U S A 2006;103:933‚Äì938.

www.StemCells.com

model to precisely dissect the nature of these epigenetic bar-
riers and their reversibility or irreversibility into rESCs after
perturbations such as those induced by nuclear transfer.

ACKNOWLEDGMENTS

This project was initiated through a collaborative program raised
between INRA and the Chinese Academy of Science (the Labio-
cem project). It was supported by an internal grant INRA to A.J.
(ACI PHASE-2008), a collaborative grant between the Pasteur
Institute of Paris, and INRA (PTR no. 331), and two grants from
the China National Basic Research Program 2006CB701501 and
2007CB947702. We are grateful to Professor Zhangjian for the
gift of the Oct4-GFP mice, to Professor Wang Xiujie for her
advice in statistical analysis of the transcriptomic data, and to
Nathalie Peynot for her help in QPCR analysis. We thank Ber-
nard Charpentier and Isabelle Bordier from the INRA MRI for
their constant support of this project and acknowledge the efÔ¨Å-
cient support of the scientiÔ¨Åc department of the French Embassy
in Beijing and of the Chinese embassy in Paris. Many thanks
also to the staff of the animal facilities both in Jouy-en-Josas and
Bejing for animal handling. J.M. was supported by a CNRS fel-
lowship and a grant from the ABIES doctorate program.

DISCLOSURE OF POTENTIAL CONFLICTS OF

INTEREST

The authors indicate no potential conÔ¨Çicts of interest.

14 Wakayama S, Jakt ML, Suzuki M et al. Equivalency of nuclear trans-
fer-derived embryonic stem cells to those derived from fertilized
mouse blastocysts. Stem Cells 2006;24:2023‚Äì2033.

15 Ding J, Guo Y, Liu S et al. Embryonic stem cells derived from
somatic cloned and fertilized blastocysts are post-transcriptionally
indistinguishable: a MicroRNA and protein proÔ¨Åle comparison. Pro-
teomics 2009;9:2711‚Äì2721.

16 Boiani M, Eckardt S, Scholer HR et al. Oct4 distribution and level in
mouse clones: consequences for pluripotency. Genes Dev 2002;16:
1209‚Äì1219.

17 Jincho Y, Sotomaru Y, Kawahara M et al. IdentiÔ¨Åcation of genes
aberrantly expressed in mouse embryonic stem cell-cloned blastocysts.
Biol Reprod 2008;78:568‚Äì576.

18 Jouneau A, Zhou Q, Camus A et al. Developmental abnormalities of
NT mouse embryos appear early after implantation. Development
2006;133:1597‚Äì1607.

19 Miki H, Wakisaka N, Inoue K et al. Embryonic rather than extraem-
bryonic tissues have more impact on the development of placental
hyperplasia in cloned mice. Placenta 2009;30:543‚Äì546.

20 Yoshimizu T, Sugiyama N, De Felice M et al. Germline-speciÔ¨Åc
expression of the Oct-4/green Ô¨Çuorescent protein (GFP) transgene in
mice. Dev Growth Differ 1999;41:675‚Äì684.

21 Zhou Q, Renard JP, Le Friec G et al. Generation of fertile cloned rats

by regulating oocyte activation. Science 2003;302:1179.

22 Lucifero D, Mertineit C, Clarke HJ et al. Methylation dynamics of

imprinted genes in mouse germ cells. Genomics 2002;79:530‚Äì538.

23 Liu JH, Zhu JQ, Liang XW et al. Diploid parthenogenetic embryos
adopt a maternal-type methylation pattern on both sets of maternal
chromosomes. Genomics 2008;91:121‚Äì128.

24 Zhao C, Yao R, Hao J et al. Establishment of customized mouse stem

cell lines by sequential nuclear transfer. Cell Res 2007;17:80‚Äì87.

25 Benjamini Y, Hochberg Y. Controlling the false discovery rate: a
practical and powerful approach to multiple testing. J R Stat Soc Ser
B 1995;57:289‚Äì300.

26 Nichols J, Zevnik B, Anastassiadis K et al. Formation of pluripotent
stem cells in the mammalian embryo depends on the POU transcrip-
tion factor Oct4. Cell 1998;95:379‚Äì391.

27 Sharova LV, Sharov AA, Piao Y et al. Global gene expression
proÔ¨Åling reveals similarities and differences among mouse pluripo-
tent stem cells of different origins and strains. Dev Biol 2007;307:
446‚Äì459.

752

Derivation of EpiSCs from Nuclear-Transfer Embryos

28 Coan PM, Burton GJ, Ferguson-Smith AC. Imprinted genes in the pla-

centa‚Äìa review. Placenta 2005;26 Suppl A:S10‚ÄìS20.

29 Schumacher A, DoerÔ¨Çer W. InÔ¨Çuence of in vitro manipulation on the
stability of methylation patterns in the Snurf/Snrpn-imprinting region
in mouse embryonic stem cells. Nucleic Acids Res 2004;32:
1566‚Äì1576.

30 Szab¬¥o PE, Mann JR. Allele-speciÔ¨Åc expression and total expression
levels of imprinted genes during early mouse development: implica-
tions for imprinting mechanisms. Genes Dev 1995;9:3097‚Äì3108.

31 Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and
embryonic stem cells are distinguished by gene expression signatures.
Cell Stem Cell 2009;5:111‚Äì123.

32 Mann MR, Chung YG, Nolen LD et al. Disruption of imprinted gene
methylation and expression in cloned preimplantation stage mouse
embryos. Biol Reprod 2003;69:902‚Äì914.

33 Suzuki J Jr, Therrien J, Filion F et al. In vitro culture and somatic cell
nuclear transfer affect imprinting of SNRPN gene in pre- and post-im-
plantation stages of development in cattle. Bmc Dev Biol 2009;9:9.

34 Humpherys D, Eggan K, Akutsu H et al. Epigenetic instability in ES

cells and cloned mice. Science 2001;293:95‚Äì97.

35 Dean W, Bowden L, Aitchison A et al. Altered imprinted gene meth-
ylation and expression in completely ES cell-derived mouse fetuses:
association with
1998;125:
2273‚Äì2282.

phenotypes. Development

aberrant

36 Chang G, Liu S, Wang F et al. Differential methylation status of
transfer derived ES (NT-ES) cells.

in nuclear

imprinted genes
Genomics 2009;93:112‚Äì119.

37 Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA. Epigenetic status

of human embryonic stem cells. Nat Genet 2005;37:585‚Äì587.

38 Adewumi O, AÔ¨Çatoonian B, Ahrlund-Richter L et al. Characterization
of human embryonic stem cell lines by the International Stem Cell
Initiative. Nat Biotechnol 2007;25:803‚Äì816.

39 Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA. Status of genomic
imprinting in human embryonic stem cells as revealed by a large
cohort of independently derived and maintained lines. Hum Mol Genet
2007;16 Spec No. 2:R243‚ÄìR251.

40 Humpherys D, Eggan K, Akutsu H et al. Abnormal gene expression
in cloned mice derived from embryonic stem cell and cumulus cell
nuclei. Proc Natl Acad Sci U S A 2002;99:12889‚Äì12894.

41 Inoue K, Kohda T, Lee J et al. Faithful expression of imprinted genes

in cloned mice. Science 2002;295:297.

42 Yang T, Adamson TE, Resnick JL et al. A mouse model for Prader-
Willi syndrome imprinting-centre mutations. Nat Genet 1998;19:
25‚Äì31.

44 Andrews SC, Wood MD, Tunster SJ et al. Cdkn1c (p57Kip2) is the
major regulator of embryonic growth within its imprinted domain on
mouse distal chromosome 7. Bmc Dev Biol 2007;7:53.

45 Aizawa T, Maruyama K, Kondo H et al. Expression of necdin, an
in developing mouse

embryonal carcinoma-derived nuclear protein,
brain. Brain Res Dev Brain Res 1992;68:265‚Äì274.

46 Grimaldi K, Horn DA, Hudson LD et al. Expression of the SmN
splicing protein is developmentally regulated in the rodent brain but
not in the rodent heart. Dev Biol 1993;156:319‚Äì323.

47 Hagiwara Y, Hirai M, Nishiyama K et al. Screening for imprinted
genes by allelic message display:
identiÔ¨Åcation of a paternally
expressed gene impact on mouse chromosome 18. Proc Nat Acad Sci
USA 1997;94:9249‚Äì9254.

48 Relaix F, Weng X, Marazzi G et al. Pw1, a novel zinc Ô¨Ånger gene
implicated in the myogenic and neuronal lineages. Dev Biol 1996;
177:383‚Äì396.

49 Takazaki R, Nishimura I, Yoshikawa K. Necdin is required for termi-
nal differentiation and survival of primary dorsal root ganglion neu-
rons. Exp Cell Res 2002;277:220‚Äì232.

50 Lee S, Walker CL, Karten B et al. Essential role for the Prader-Willi
syndrome protein necdin in axonal outgrowth. Hum Mol Genet 2005;
14:627‚Äì637.

51 Muscatelli F, Abrous DN, Massacrier A et al. Disruption of the mouse
Necdin gene results in hypothalamic and behavioral alterations remi-
niscent of the human Prader-Willi syndrome. Hum Mol Genet 2000;9:
3101‚Äì3110.

52 Taniura H, Taniguchi N, Hara M et al. Necdin, a postmitotic neuron-
speciÔ¨Åc growth suppressor, interacts with viral transforming proteins
and cellular
J Biol Chem 1998;273:
720‚Äì728.

transcription factor E2F1.

53 Kurita M, Kuwajima T, Nishimura I et al. Necdin downregulates
CDC2 expression to attenuate neuronal apoptosis. J Neurosci 2006;26:
12003‚Äì12013.

54 Kuwajima T, Nishimura I, Yoshikawa K. Necdin promotes GABAer-
gic neuron differentiation in cooperation with Dlx homeodomain pro-
teins. J Neurosci 2006;26:5383‚Äì5392.

55 Li L, Keverne EB, Aparicio SA et al. Regulation of maternal behavior
and offspring growth by paternally expressed Peg3. Science 1999;284:
330‚Äì333.

56 Hentges KE, Pollock DD, Liu B et al. Regional variation in the den-

sity of essential genes in mice. PLoS Genet 2007;3:e72.

57 Meissner A, Mikkelsen TS, Gu H et al. Genome-scale DNA methyla-
tion maps of pluripotent and differentiated cells. Nature 2008;454:
766‚Äì770.

58 Allegrucci C, Young LE. Differences between human embryonic stem

cell lines. Hum Reprod Update 2007;13:103‚Äì120.

43 Lefebvre L, Viville S, Barton SC et al. Abnormal maternal behaviour
and growth retardation associated with loss of the imprinted gene
Mest. Nat Genet 1998;20:163‚Äì169.

59 Balbach ST, Jauch A, Bohm-Steuer B et al. Chromosome stability dif-
fers in cloned mouse embryos and derivative ES cells. Dev Biol 2007;
308:309‚Äì321.

See www.StemCells.com for supporting information available online.

